As expected, treatment of reproterol significantly attenuated oleic acid-induced LD biogenesis and HFD-induced hepatic steatosis likely via increasing ATGL-mediated lipolysis and decreasing SREBP1c transcriptional activity. The gene discussed is SREBF1; the disease is fatty liver disease.